Evidence map›Paper›PMID 32859148›Full record

ArticleBMC bioinformatics2020

MCMSeq: Bayesian hierarchical modeling of clustered and repeated measures RNA sequencing experiments.

Brian E Vestal, Camille M Moore, Elizabeth Wynn, Laura Saba, Tasha Fingerlin, Katerina Kechris

Open access · goldAbstract read
In one paragraph

Article in BMC bioinformatics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Brian E VestalCenter for Genes, Environment and Health, National Jewish Health, 1400 Jackson St, Denver, 80206, CO, USA.
Camille M MooreCenter for Genes, Environment and Health, National Jewish Health, 1400 Jackson St, Denver, 80206, CO, USA. mooreca@njheath.org.
Elizabeth WynnDepartment of Biostatistics and Informatics, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Laura SabaDepartment of Pharmaceutical Sciences, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA.
Tasha FingerlinCenter for Genes, Environment and Health, National Jewish Health, 1400 Jackson St, Denver, 80206, CO, USA.
Katerina KechrisDepartment of Biostatistics and Informatics, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
National Jewish Health · USUniversity of Colorado Anschutz Medical Campus · USUniversity of Colorado Denver · US

Funding

The Heritable Transcriptome and AlcoholismR24AA013162 · NIAAA · UNIVERSITY OF COLORADO DENVER · PI HOFFMAN, PAULA, SABA, LAURA MAREN · 2001 to 2021
$14.2M
TIM Project NIDA P30 CenterP30DA044223 · NIDA · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI WILLIAMS, ROBERT W. · 2017 to 2021
$3.9M
Genomic regulatory sequence analysis for alcohol-related phenotypesK01AA016922 · NIAAA · UNIVERSITY OF COLORADO DENVER · PI KECHRIS-MAYS, KATHERINA · 2007 to 2011
$737k
NIAAA NIH HHS R24 AA013162NIDA NIH HHS P30 DA044223
6 · The paper itself

Abstract

backgroundAs the barriers to incorporating RNA sequencing (RNA-Seq) into biomedical studies continue to decrease, the complexity and size of RNA-Seq experiments are rapidly growing. Paired, longitudinal, and other correlated designs are becoming commonplace, and these studies offer immense potential for understanding how transcriptional changes within an individual over time differ depending on treatment or environmental conditions. While several methods have been proposed for dealing with repeated measures within RNA-Seq analyses, they are either restricted to handling only paired measurements, can only test for differences between two groups, and/or have issues with maintaining nominal false positive and false discovery rates. In this work, we propose a Bayesian hierarchical negative binomial generalized linear mixed model framework that can flexibly model RNA-Seq counts from studies with arbitrarily many repeated observations, can include covariates, and also maintains nominal false positive and false discovery rates in its posterior inference.

resultsIn simulation studies, we showed that our proposed method (MCMSeq) best combines high statistical power (i.e. sensitivity or recall) with maintenance of nominal false positive and false discovery rates compared the other available strategies, especially at the smaller sample sizes investigated. This behavior was then replicated in an application to real RNA-Seq data where MCMSeq was able to find previously reported genes associated with tuberculosis infection in a cohort with longitudinal measurements.

conclusionsFailing to account for repeated measurements when analyzing RNA-Seq experiments can result in significantly inflated false positive and false discovery rates. Of the methods we investigated, whether they model RNA-Seq counts directly or worked on transformed values, the Bayesian hierarchical model implemented in the mcmseq R package (available at https://github.com/stop-pre16/mcmseq ) best combined sensitivity and nominal error rate control.

Indexed as

User-Computer InterfaceBayes TheoremHumansMonte Carlo MethodRNASequence Analysis, RNATuberculosisRNACorrelated dataLongitudinal dataMarkov chain Monte CarloRNA-Seq

Identifiers

PMID32859148
PMCPMC7455910
OpenAlexW3081560772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.